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Abstract. Cadherins are a family of cell-cell adhesion 
molecules which play a central role in controlling mor- 
phogenetic movements during development. Cadherin 
function is regulated by its association with the actin 
containing cytoskeleton, an association mediated by a 
complex of cytoplasmic proteins, the catenins: e~, [3, and 
~/. Phosphorylated tyrosine residues on 13-catenin are 
correlated with loss of cadherin function. Consistent 
with this, we find that only nontyrosine phosphorylated 
13-catenin is associated with N-cadherin in El0 chick 
retina tissue. Moreover, we demonstrate that a PTP1B- 
like tyrosine phosphatase associates with N-cadherin 
and may function as a regulatory switch controlling 
cadherin function by dephosphorylating 13-catenin, 
thereby maintaining cells in an adhesion-competent 
state, 
The PTP1B-Iike phosphatase is itself tyrosine phos- 
phorylated. Moreover, both direct binding experiments 
performed with phosphorylated and dephosphorylated 
molecules, and treatment of cells with tyrosine kinase 
inhibitors indicate that the interaction of the PTPIB- 
like phosphatase with N-cadherin depends on its ty- 
rosine phosphorylation. Concomitant with the tyrosine 
kinase inhibitor-induced loss of the PTP1B-Iike phos- 
phatase from its association with N-cadherin, phospho- 
rylated tyrosine residues are retained on 13-catenin, the 
association of N-cadherin with the actin containing cy- 
toskeleton is lost and N-cadherin-mediated cell adhe- 
sion is prevented. Tyrosine phosphatase inhibitors also 
result in the accumulation of phosphorylated tyrosine 
residues on ~-catenin, loss of the association of N-cad- 
herin with the actin-containing cytoskeleton, and pre- 
vent N-cadherin mediated adhesion, presumably by 
directly blocking the function of the PTP1B-Iike phos- 
phatase. 
We previously showed that the binding of two ligands 
to the cell surface N-acetylgalactosaminylphospho- 
transferase (GalNAcPTase), the monoclonal antibody 
1Bll and a proteoglycan with a 250-kD core protein, 
results in the accumulation of phosphorylated ty- 
rosine residues on 13-catenin, uncoupling of N-cadherin 
from its association with the actin containing cytoskele- 
ton, and loss of N-cadherin function. We now report 
that binding of these ligands to the GalNAcPTase re- 
suits in the absence of the PTP1B-Iike phosphatase 
from its association with N-cadherin as well as the loss 
of the tyrosine kinase and tyrosine phosphatase activi- 
ties that otherwise co-precipitate with N-cadherin. Con- 
trol antibodies and proteoglycans have no such effect. 
This effect is similar to that observed with tyrosine ki- 
nase inhibitors, suggesting that the GalNAcPTase/pro- 
teoglycan interaction inhibits a tyrosine kinase, thereby 
preventing the phosphorylation of the PTP1B-like 
phosphatase, and its association with N-cadherin. 
Taken together these data indicate that a PTP1B-like 
tyrosine phosphatase can regulate N-cadherin function 
through its ability to dephosphorylate 13-catenin and 
that the association of the phosphatase with N-cadherin 
is regulated via the interaction of the GalNAcPTase 
with its proteoglycan ligand. In this manner the Gal- 
NAcPTase-proteoglycan interaction may play a major 
role in morphogenetic cell and tissue interactions dur- 
ing development. 
T 
HE cadherin family of calcium-dependent adhesion 
molecules mediate  homophilic cell-cell  adhesion 
(reviewed in Grunwald, 1993). During normal de- 
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velopment they are suggested to play an important causal 
role in the onset and cessation of cell migration (Akitaya 
and Bronner-Fraser, 1992; reviewed in Vallrs et al., 1991) 
and in the separation of tissues  (reviewed in Takeichi, 
1991). Three lines  of evidence have been marshaled in 
support of this critical role for cadherins in development: 
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opment (Detrick et al., 1990; Dufour et al., 1994; Levine et 
al., 1994; Heasman et al., 1994a,b) and failure of implanta- 
tion (Larue et al., 1994; Riethmacher et al., 1995). Second, 
in vitro analysis of function reveals that N-cadherin plays 
an important role in the outgrowth of nerve fibers (Bixby 
and Zhang, 1990; Gaya Gonzalez et al.,  1991; Matsunaga 
et al.,  1988; Doherty et al., 1991) and E-cadherin plays a 
crucial  role  in  the  formation  of epithelia  (reviewed  in 
Eaton and Simons, 1995). Third, an extensive body of data 
demonstrates that cadherins are temporally and spatially 
regulated in a  manner that correlates with key develop- 
mental events (reviewed in Takeichi, 1991; Ranscht, 1991; 
Grunwald, 1993; Dalseg et al., 1994). 
The function of cadherins depends on their association 
with the actin containing cytoskeleton. Deletion or trunca- 
tion of the cytoplasmic domain of cadherin results in loss 
of function, in spite of continued expression at the cell sur- 
face (Nagafuchi and Takeichi, 1988,  1989; Kintner, 1992; 
Fugimori  and  Takeichi,  1993).  The  interaction  of cad- 
herins with the actin containing cytoskeleton is mediated 
by ec, 13, and ~ catenins (reviewed in Magee and Buxton, 
1991;  Kemler, 1993;  Gumbiner, 1993).  Consistent with a 
role for the catenins in linking cadherins to the cytoskele- 
ton, loss of cadherin function has been correlated with 
alterations in catenins. Loss of ec-catenin has been corre- 
lated with loss of cadherin function in cell lines (Shimoyama 
at al., 1992; Breen et al., 1994; Ochiai et al., 1994a), which 
in one case may be due to a deletion in the et-catenin gene 
(Oda et al., 1993). Mutation of 13-catenin (Kawanishi et al., 
1995), as well as the presence of phosphorylated tyrosine 
residues  on  13-catenin  are  also  correlated with  a  loss  of 
cadherin-mediated  adhesion.  We  have shown  that  the 
interaction of the chick retina N-acetylgalactosaminylphos- 
photransferase (GalNAcPTase) with its proteoglycan ligand 
results  in  the  accumulation  of phosphorylated  tyrosine 
residues on [3-catenin  concomitant with loss  of cadherin- 
mediated adhesion and uncoupling of cadherin from its as- 
sociation with the cytoskeleton (Balsamo et al., 1995). Ad- 
ditionally, treatment  of human  cancer cells with growth 
factors (Shibamoto et al.,  1994) or transformation of cells 
with v-src (Behrens et al., 1993; Hamaguchi et al., 1993) or 
Rous sarcoma virus (Matsuyoshi et al., 1992) results in the 
accumulation of phosphorylated tyrosine residues on 13-cat- 
enin  concomitant with  loss  of cadherin-mediated  adhe- 
sion. 
Taken together these data suggest that the presence or 
absence of phosphorylated tyrosine residues on 13-catenin 
appears to be a critical parameter in controlling cadherin 
function,  possibly  by  regulating  the  association  of cad- 
herins with the cytoskeleton. In this manuscript we have 
examined the regulation of the tyrosine phosphorylation/ 
dephosphorylation of 13-catenin. In El0 chick retina tissue 
only [3-catenin molecules lacking phosphorylated tyrosine 
residues  are  associated  with  N-cadherin.  Moreover,  we 
show  that  a  novel  PTP1B-like  tyrosine  phosphatase 
(PTP1B-LP)  1 is associated with N-cadherin and that the ac- 
cumulation of phosphorylated tyrosine residues on 13-cate- 
1.  Abbreviations  used  in  this  paper:  B,  bound;  F,  flowthrough;  GaP 
NAcPTase, N-acetylgalactosaminylphosphotransferase;  PTP1B-LP, PTP1B- 
like tyrosine phosphatase; PG, proteoglycan. 
nin, uncoupling of cadherin from its association with the 
cytoskeleton, and loss of cadherin-mediated adhesion are 
correlated  with  inhibition  of the  function of this  phos- 
phatase,  or loss  of its  association with  N-cadherin.  Fur- 
thermore, the  association of the PTPIB-LP with N-cad- 
herin requires its tyrosine phosphorylation as demonstrated 
by both direct binding experiments and by experiments in 
which cells were treated with  tyrosine kinase inhibitors. 
We also show that the binding to cells of GalNAcPTase 
ligands results in the loss of tyrosine kinase and tyrosine 
phosphatase activity that co-precipitates with N-cadherin 
and the failure of the PTP1B-LP to associate with N-cad- 
herin. Based on these  observations we propose that the 
PTP1B-LP acts  as  a  regulatory switch  modulating  cad- 
herin-mediated cell--cell adhesion and that GalNAcPTase- 
proteoglycan interactions can alter the state of this switch 
by inhibiting a tyrosine kinase whose activity is necessary 
to keep the phosphatase bound to N-cadherin. 
Materials and Methods 
Antibodies 
The anti-N-cadherin hybridoma cell line NCD-2 is a rat IgG and was gen- 
erously provided by M. Takeichi (Kyoto University, Kyoto, Japan). The 
anti-13-catenin antibody used in  immunoprecipitation experiments is a 
rabbit polyclonal, prepared from a  15-amino acid synthetic peptide de- 
rived from the published sequence (Butz  et  al.,  1992).  In experiments 
where immunoblotting was also necessary, a mouse monoclonal IgG anti- 
13-catenin antibody from Transduction Labs (Lexington, KY) was used. 
Anti-phosphotyrosine antibody PY20, horseradish peroxidase-conjugated 
anti-phosphotyrosine antibody RC20H, biotin conjugated anti-phospho- 
tyrosine antibody RC20B,  and  anti-PTP1B  antibody, prepared from a 
166--amino  acid fragment corresponding to the carboxy terminus of the 
enzyme, were also mouse IgG's from Transduction Labs. Streptavidin- 
conjugated magnetic beads were from Promega Biotech (Madison, WI). 
The anti-actin antibody was a monoclonal mouse IgG from Chemicon Inc. 
(Temecula, CA). HRP-conjugated goat anti-rat, -rabbit, or -mouse IgG 
or IgM were from Cappel (Organon Teknika Corp., Durham, NC). HRP- 
conjugated Streptavidin was from Amersham Corp. (Chicago, IL). 
The  monoclonal anti-GalNAcPTase  antibodies, 7A2  and  1Bll,  are 
mouse IgMs prepared in our laboratory and partially purified from culture 
medium as described (Scott et al., 1990; Balsamo et al., 1991). Both anti- 
bodies bind equally to the cell surface GalNAcPTase, but only 1Bll trig- 
gers the pathway resulting in inhibition of N-cadherin-mediated adhesion 
(Balsamo et al., 1991). 
Other Reagents 
o-Vanadate, genistein, and protease inhibitors were from Sigma Chemical 
Co. (St. Louis, MO). Phenylarsine oxide was from Eastman Kodak and 
herbimycin from Calbiochem-Behring Corp. (San Diego, CA). Chicken 
brain-derived chondroitin sulfate proteoglycans (PG) with core molecular 
masses of 250 kD (250-kD PG) and 400 kD (400-kD PG) were purified 
and core proteins prepared according to Ernst et al. (1995). We have pre- 
viously demonstrated that the 250-kD core protein, but not the 400-kD 
core protein, binds directly to the GalNAcPTase resulting in inhibition of 
N-cadherin-mediated adhesion (Balsamo et al., 1995). 
Preparation of a Rapidly Sedimenting Fraction from 
Triton X-IO0 Tissue Extracts 
This procedure has been described in previous publications (Balsamo 
et al., 1991, 1995). Briefly, neural retina tissue or cell suspensions were ho- 
mogenized in Triton buffer (five retinas/ml; 1% Triton X-100 in 50 mM 
Tris-HCl, pH 8.0 and 150 mM NaCI) containing protease and phosphatase 
inhibitors and DNase (5 p,g/ml each leupeptin and antipain, 1 mM PMSF, 
10 mM NaF, 4 mM o-vanadate, 100 p,g/ml DNAase). After 30 min on ice, 
the homogenates were clarified by centrifugation at 14,000 g. To prepare 
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ered on sucrose (100 ~1 of 50% and 1 ml of 20% sucrose in Triton buffer) 
and centrifuged for 30 rain at 150,000 g. The fraction from the 20/50% in- 
terface down constitutes the rapidly sedimenting fraction, referred to as 
the H  fraction, and includes ~80% of the total N-cadherin present. This 
distribution remains unchanged by treatment of cells with phosphatase or 
kinase inhibitors as described below. 
Affinity Purification of N-Cadherin and Analysis of 
Associated Proteins 
IgG prepared from NCD-2 culture media was coupled to CnBr-activated 
Sepharose (Sigma Chemical Co.) according to the manufacturer's instruc- 
tions. The H fraction from 20 retinas was diluted with an equal volume of 
Triton buffer and applied to the column. The column was washed with 10 
volumes of Triton buffer and eluted with two column volumes of 50 mM 
diethylamine. The eluate was neutralized with 1 M Tris-HC1, pH 8, before 
further use. 
To determine the distribution of tyrosine phosphorylated 13-catenin in 
retina tissue, the bound and flowthrough fractions from the NCD-2 affin- 
ity column were concentrated using a Centricon 30 (Amieon Corp., Dan- 
vers, MA), made 1% in SDS to disrupt protein-protein interactions, di- 
luted with Triton buffer to a final concentration of 0.1% SDS, and then 
immunoprecipitated with anti-13-catenin. The immunoprecipitates were 
fractionated by SDS-PAGE, transferred to PVDF membranes and probed 
with anti-phosphotyrosine or anti-13-catenin antibodies. 
To evaluate whether a  PTP1B-Iike phosphatase was associated with 
N-cadherin and whether it contained phosphorylated tyrosine residues, 
the bound and  flow-through fractions from an NCD-2 affinity column 
were treated as above and immunoprecipitated with anti-PTPiB or PY20. 
The immunoprecipitates were fractionated by SDS-PAGE, and immuno- 
blotted with anti-phosphotyrosine antibody RC20H or anti-PTPIB. 
lmmunoprecipitations were carried out for 4 h at 4°C. 100 ~.g of mag- 
netic beads (Advanced Magnetics, Cambridge, MA) conjugated with the 
appropriate second antibody were then added and the mixture incubated 
for 1 h at 4°C with end to end rotation. The immunoprecipitates were col- 
lected using a  magnetic stand, the beads washed five times with Triton 
buffer, and precipitated material eluted with SDS-PAGE sample buffer. 
Immunoblotting 
SDS-polyacrylamide gels were transferred to PVDF membranes using a 
semi-dry transfer unit (Bio-Rad  Laboratories,  Cambridge, MA) for 36 
min at 15V. The membranes were blocked for 1 h at 37°C in 5% dry milk 
solids in TBST (50 mM Tris-HCl, 150 mM NaC1, 0.1% Tween 20, pH 8) or 
in 3% BSA-1% gelatin in TBST when reacting with anti-phosphotyrosine 
antibodies. The membranes were incubated with the primary antibody for 
1 to 2 h, washed for 30 min in three changes of TBST, and incubated with 
HRP-conjugated secondary antibody (1:1,000 in TBST) for 45 min. After 
washing the membranes were developed using the ECL system (Amer- 
sham Corp., Arlington Heights, IL). When necessary the membranes were 
stripped of bound antibody by incubating stripping buffer (100 mM 2-mer- 
captoethanol, 2%  SDS, 62.5  mM Tris-HCl, pH 6.8) for 30 min at 50°C, 
washed in TBST, blocked, and reused as above. 
Adhesion Assays 
Single cells were prepared from 3H-labeled E9 chick retina by trypsin dis- 
sociation in the presence of calcium (Grunwald et al., 1980; Brackenbury 
et al., 1981; Magnani et al., 1981). Such cells have an intact and functional 
cadherin adhesion system. Labeling of tissues and adhesion of labeled 
cells to immobilized N-cadherin or the anti-N-cadherin antibody NCD-2 
was assayed as described previously (Balsamo et al., 1991). 
To 3H-label cells during a prolonged treatment with tyrosine kinase in- 
hibitors, single cells were incubated in F12 medium containing 10 IxCi 3H- 
leucine, 50 Ixg/ml gentamycin, and 1 p.g/ml herbimycin A, on 30 mm Petri 
dishes (~1  ×  107 cells/2 ml), overnight, at 37°C, under an atmosphere of 
10% CO2. Just before assaying, cells were removed from the Petri plate by 
gentle flushing with a Pasteur pipette, collected by centrifugation, washed 
and resuspended in HBSGKCa (20 mM Hepes, pH 7.2,  150 mM NaCl, 2 
mM glucose, 3 mM KCI, and 1 mM Ca). 
To correlate the effects of tyrosine kinase and tyrosine phosphatase in- 
hibitors and GalNAcPTase ligands on adhesion with the phosphorylated 
tyrosine content of 13-catenin  and with the association of the PTPIB-LP 
with N-cadherin, single cells were incubated with or without the desired 
inhibitor in HBSGKCa for 45 min at 37°C and 70 rpm (~108 cells/3 ml). 
The ceils were collected, H  fractions were prepared and the phosphory- 
lated tyrosine content of 13-catenin  or the association of the PTP1B-LP 
with N-cadherin analyzed as described above. 
Immunofluorescence 
E9 neural retina cells prepared as above were plated on eoverslips coated 
with poly-L-lysine (50 i~g/ml  in PBS) and incubated overnight in DME 
containing 10% FCS and 1% ITS (insulin, transferrin, selenium; GIBCO 
BRL, Gaithersburg, MD). The cells were fixed in 4% paraformaldehyde 
in PBS and permeabilized with 0.1% Triton X-100 in PBS for 10 min at 
room temperature. The cells were then incubated for 1 h, at room temper- 
ature with the desired antibody diluted in DME containing 5% goat se- 
rum. The cells were washed four times with DME/goat serum and incu- 
bated  for  another  hour  with  rhodamine-conjugated  second  antibody. 
After washing another four times in the same buffer, the coverslips were 
mounted and examined under epifluorescence. 
Preparation of Biotinylated N-Cadherin and 
Overlay Assays 
Purified N-cadherin was prepared according to the procedure described 
by Bixby and Zhang (1990) and biotinylated using the ECL protein bioti- 
nylation kit (Amersham, Corp.). The purity of the preparation was as- 
sessed by SDS-PAGE followed by transfer to PVDF membrane and prob- 
ing with HRP-streptavidin or anti-N-cadherin antibody followed by HRP 
goat anti-rat IgG (see Fig. 8). 
To  assay direct  binding between N-cadherin and the ~I'P1B-LP,  H 
preparations  were  immunoprecipitated with  anti-PTP1B  antibody,  the 
precipitates fractionated by SDS-PAGE and transferred to PVDF mem- 
branes. The membranes were rinsed in 50 mM Tris buffer, pH 9, contain- 
ing 5 mM MgCI2, 2 mM CaC12 and 1 mM PMSF. Parallel lanes were incu- 
bated in the same buffer with  10 U/ml alkaline phosphatase (Promega 
Biotec, Madison, WI) with or without 4 mM o-vanadate for 1 h, at 37°C to 
inhibit phosphatase activity. The membranes were blocked for 30 min in 
3% BSA in 50 mM Tris (pH 8.0) with 150 mM NaC1 and incubated over- 
night with biotinylated N-cadherin in the Tris-NaCl buffer with 2  mM 
CaClz.  After  extensive washing, the  membranes were  incubated  with 
HRP-streptavidin and developed using enhanced chemiluminescence. 
Determination of Protein Tyrosine Kinase and Protein 
Tyrosine Phosphatase Activity 
Single cells were  incubated  with  the desired  perturbing  agent in  HB- 
SGKCa for 45 min at 37°C and 70 rpm (~ 10  ~ cells/3 ml). The N-cadherin 
bound fraction was prepared from an H fraction as above. Aliquots were 
tested for kinase or phosphatase activity using the respective non radioac- 
tive enzyme assay kits (Boehringer-Mannheim Biochemicals, Indianapo- 
lis,  IN).  Tyrosine phosphatase activity was measured using a  stable ty- 
rosine  phosphorylated  peptide  which  is  biotinylated  at  the  amino 
terminus. This substrate is bound to microtiter wells coated with streptavi- 
din and reacted with the source of tyrosine phosphatase. Phosphotyrosine 
residues are determined immunochemieally with a specific anti-phospho- 
tyrosine antibody covalently bound to peroxidase. Absorbance at 405 nm 
reflects the amount of phosphotyrosine residues remaining: the higher the 
absorbance, the lower the phosphatase activity. 
The protein tyrosine kinase assay measures addition of a phosphate to 
tyrosine residues in a synthetic peptide substrate labeled with biotin. The 
peptide is incubated with the kinase source in suspension, the reaction 
stopped by the specific inhibitor piceatannol and the biotinylated peptide 
attached to streptavidin coated microtiter wells. As in the phosphatase as- 
say, phosphotyrosine residues are determined by a specific anti-phospho- 
tyrosine antibody, and activity determined as absorbance at 405 nm. In 
this case, higher absorbance values correspond to higher kinase activity. 
Results 
Only fl-Catenin Lacking Phosphorylated Tyrosine 
Residues Is Associated with N-Cadherin 
There is a correlation between the presence of phosphory- 
lated tyrosine residues on 13-catenin  and loss of cadherin 
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Hamaguchi et al., 1993; Shibamoto et al., 1994; Balsamo et 
al., 1995). One possible interpretation of this correlation is 
that the presence of phosphorylated tyrosine residues  on 
13-catenin prevents its association with N-cadherin and there- 
fore cadherin is unable to form its critical connection to the 
actin containing cytoskeleton. To further test this idea, we 
examined  the  association  of nontyrosine-phosphorylated 
and  tyrosine-phosphorylated  [3-catenin  with  N-cadherin. 
A  14,000-g supernatant  from El0  retina  tissue  homoge- 
nized in Triton X-100 was applied  to an anti-N-cadherin 
affinity  column  and  separated  into  bound  (B)  and  un- 
bound or flowthrough (F) fractions.  Greater than 90%  of 
the N-cadherin in the extract was recovered in the bound 
fraction  (not  shown).  The  bound  and  unbound fractions 
were then  treated  with SDS to eliminate  protein-protein 
interactions  and immunoprecipitated  with  anti-13-catenin 
antibody. These precipitates were immunoblotted with anti- 
13-catenin and anti-phosphotyrosine antibodies.  Although 
similar amounts of [3-catenin were present in the B  and F 
fractions,  [3-catenin  that  had  coprecipitated  with  N-cad- 
herin (B fraction) was not phosphorylated on tyrosine res- 
idues  whereas  13-catenin that  did  not co-precipitate  with 
N-cadherin  (F  fraction)  contained  phosphorylated  ty- 
rosine residues (Fig. 1). 
Inhibition of  Either Tyrosine Kinases or Tyrosine 
Phosphatases Results in fl-Catenin Containing 
Phosphorylated Tvrosine Residues, Uncoupling of 
N-Cadherin from Its Association with Actin and 
Inhibition of Cadherin-mediated Adhesion 
To determine  the  roles  of tyrosine  kinases  and  tyrosine 
phosphatases in regulating the level of phosphorylated ty- 
rosine residues on [3-catenin, El0 retina cells were assayed 
for cadherin-mediated  adhesion  and  for phosphorylated 
tyrosine residues on [3-catenin in the presence or absence of 
specific tyrosine kinase and phosphatase inhibitors.  Geni- 
stein (Akiyama et al., 1987) or herbimycin A  (Uehara and 
Fukazawa, 1991) were used to inhibit tyrosine kinase; per- 
Figure  1.  13-Catenin  phos- 
phorylated  on  tyrosine  resi- 
dues  is  not  associated  with 
N-cadherin.  (Top) Anti-N- 
cadherin  bound  (B)  and 
flowthrough  (F)  fractions 
from  the  14,000  g  superna- 
tant of the Triton X-100 ho- 
mogenate were made 1%  in 
SDS to disrupt  protein-pro- 
tein  interactions  and  immu- 
noprecipitated  with  anti-13- 
catenin antibody. The precip- 
itates  were  fractionated  by 
SDS-PAGE  and  immuno- 
blotted with anti-phosphoty- 
rosine  antibody PY20.  (Bot- 
tom) The same transfer was 
stripped  and  reprobed  with 
anti-13-catenin  antibody. The arrowhead at the right labeled 13 
cat.  indicates the position of 13-catenin. The migration of stan- 
dard proteins  is indicated  at the  left by their molecular mass 
(xlO-S). 
vanadate  (Gordon,  1991; Volberg et  al.,  1991) or pheny- 
larsine oxide (Levenson and Blackshear,  1989) were used 
to inhibit tyrosine phosphatase. Both sets of inhibitors re- 
sult  in  the  inhibition  of  N-cadherin-mediated  adhesion 
(Fig. 2 A). Fig. 2 A  represents adhesion to anti-N-cadherin 
antibody NCD-2, however, identical results were obtained 
Figure 2.  The effect of tyrosine kinase and tyrosine phosphatase 
inhibitors  on  N-cadherin-mediated  adhesion  (A),  13-catenin 
phosphorylation (B), and the association of N-cadherin with actin 
(C).  (A)  Adhesion.  all-labeled  single  cells  were  preincubated 
with the indicated additive for 45 rain and added to microtiter 
wells coated with anti-cadherin antibody NCD-2. Adhesion was 
calculated as percent of control value. The data represent the re- 
suits of three independent experiments and each point is the av- 
erage  of three  measurements.  Co, no additives;  Gen, 150  IxM 
genistein;  Herb., 1 Ixg/ml herbimycin; pVn, 2 mM per-vanadate; 
PAO, 10 txg/ml phenylarsine oxide.  (B) Phosphorylated tyrosine 
residues on 13-catenin. Single cells were either immediately pro- 
cessed for analysis  (0) or incubated for 45 rain in the presence of: 
45, no additives;  Gen, 150 ~M genistein;  PAO, 10 Ixg/ml pheny- 
larsine  oxide.  H  fractions  were  prepared,  immunoprecipitated 
with  anti-13-catenin  antibody, the immunoprecipitates  fraction- 
ated  by SDS-PAGE, and immunoblotted with anti-phosphoty- 
rosine antibody PY20. The arrow labeled 13 cat indicates the posi- 
tion of 13-catenin. The migration of standard proteins is indicated 
at the left by their molecular mass (×10-3).  (C) Association of 
N-cadherin with actin. Single cells were treated as in B, the H frac- 
tion isolated and immunoprecipitated with anti-N-cadherin anti- 
body NCD-2. The immunoprecipitates were fractionated by SDS- 
PAGE on a 10% gel and immunoblotted with an anti-actin anti- 
body. As a control, the same gel was stripped and immunoblotted 
with anti-N-cadherin  antibody NCD-2 (top). Co, no additions; 
PAO, 10 p~g/ml phenylarsine oxide; Gen, 150 p,M genistein.  The 
arrowheads  labeled  N-Cad  and  actin  indicate  the  position  of 
N-cadherin  and  actin,  respectively.  The migration of standard 
proteins is indicated at the left by their molecular mass (× 10-3). 
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not shown). Fig. 2 B shows the results of kinase and phos- 
phatase  inhibitors  on  phosphorylation of  ~-catenin.  As 
seen in intact tissue (Fig. 1), immediately following disso- 
ciation of tissue into single cells there is a population of ty- 
rosine phosphorylated [3-catenin. However, after 45 min of 
culture  under  conditions  allowing  adhesion,  phosphory- 
lated tyrosine residues are no longer detected on 13-cate- 
nin.  Consistent with their inhibitory effect on adhesion, 
the presence of tyrosine kinase or tyrosine phosphatase in- 
hibitors prevent the removal of phosphate residues from 
[3-catenin (Fig. 2 B). The amount of total 13-catenin in each 
lane is similar (not shown), indicating that the differences 
represent changes in the degree of tyrosine phosphoryla- 
tion. Thus adhesion competent cells incubated in suspen- 
sion for 45 min have a lower level of phosphorylated ty- 
rosine  residues  on  [3-catenin than  cells in vivo, possibly 
because  during  cell  preparation  endogenous  inhibitors 
(such  as  the  250-kD  PG;  Balsamo  et  al.,  1995)  are  re- 
moved, allowing the removal of tyrosine phosphate from 
13-catenin. 
To determine if these drugs also affect the association of 
N-cadherin with actin, we determined if actin remains as- 
sociated with the N-cadherin--catenin complex in the rap- 
idly sedimenting fraction (H) isolated from the 14,000 g 
supernatant from Triton X-100 homogenates of El0 retina 
cells. We have previously shown that the H  fraction con- 
tains cadherin-[3-catenin-actin complexes in adhesion com- 
petent cells, but not in cells rendered adhesion incompe- 
tent  by  treatment  with  monoclonal  anti-GalNAcPTase 
antibody 1Bll or the GalNAcPTase binding proteoglycan 
with a  250-kD  core protein (Balsamo et al.,  1991,  1995; 
Bauer et al., 1992). Cells were incubated with tyrosine ki- 
nase and tyrosine phosphatase inhibitors; the H  fraction 
prepared, immunoprecipitated with anti-N-cadherin anti- 
body NCD-2 and the precipitates analyzed by immunoblot 
with anti-actin  antibody (Fig. 2  C).  Indeed, both sets  of 
drugs result in a reduction in the amount of actin associ- 
ated with N-cadherin. 
A PTPIB-like Phosphatase Is 
Associated with N-Cadherin and Is Itself 
Tyrosine Phosphorylated 
The  fact  that  incubation  in  the  presence  of  tyrosine 
phosphatase inhibitors increases the level of phosphate on 
~3-catenin suggests that tyrosine phosphatases are involved 
in the removal of phosphate from 13-catenin.  To directly 
test for the  association of protein tyrosine phosphatases 
with N-cadherin-catenin  complexes, the  H  fraction was 
passed over an  anti-N-cadherin affinity column and  the 
bound  and  flowthrough fractions analyzed for the pres- 
ence of tyrosine phosphatases  using  commercially avail- 
able  antibodies.  Strikingly, a  ~37-kD  polypeptide cross- 
reactive with  anti-PTP1B  antibody is  consistently found 
associated with the N-cadherin bound fraction, but not in 
the flowthrough fraction (Fig. 3). 
Short term incubations in the presence of tyrosine ki- 
nase inhibitors prevent the dephosphorylation of 13-cate- 
nin seen following preparation of single cells (Fig. 2 B). 
This suggests that a tyrosine kinase is involved in one or 
more steps in the removal of phosphate from tyrosine resi- 
Figure 3.  Association of a tyrosine phosphatase  with the N-cad- 
herin--catenin complex. Flowthrough (F) and bound (B) fractions 
from an H preparation fractionated on an anti-N-cadherin affin- 
ity column were made 1% in SDS to dissociate protein-protein 
interactions. After dilution of the SDS to 0.1%, the F and B frac- 
tions were immunoprecipitated  with the indicated antibody (IP), 
the immunoprecipitates  fractionated by SDS-PAGE on a 7.5% 
gel and immunoblotted  as indicated. PY20 is an anti-phosphoty- 
rosine antibody. The heavily stained bands  ~55-kD correspond 
to IgG heavy chain  and are absent from the second  panel as 
RC20H  is  an  anti-phosphotyrosine  antibody  conjugated  with 
HRP and this serves as primary and secondary antibody. The mi- 
gration of standard proteins is indicated at the left by their molec- 
ular mass (x 10-3). 
dues on 13-catenin, possibly by modulating the effect of the 
phosphatase. To test this possibility we determined if the 
PTP1B-LP itself was tyrosine phosphorylated. The bound 
and  flowthrough  fractions  from the  N-cadherin  affinity 
column were treated with SDS to dissociate protein com- 
plexes and immunoprecipitated with anti-phosphotyrosine 
antibody. The immunoprecipitated material was fraction- 
ated by SDS-PAGE and immunoblotted with anti-PTP1B 
antibody. The results of this experiment reveal that cad- 
herin-bound PTP1B-LP is indeed tyrosine phosphorylated 
(Fig. 3). When these antibodies are used in the reverse or- 
der (NCD-2 bound and flowthrough fractions precipitated 
with anti-PTP1B antibody then blotted with anti-phospho- 
tyrosine antibody), similar results are obtained, further in- 
dicating  that  the  PTP1B-LP is  tyrosine  phosphorylated 
(Fig. 3). 
To further reinforce our conclusion that the PTP1B-LP 
is  localized to cadherin/catenin complexes we  examined 
the distribution of the immunoreactive species immuno- 
histochemically. The PTP1B-LP is distributed at the cell 
periphery (Fig. 4, A and B) and on neurites (Fig. 4 A). This 
pattern is similar to that seen for [3-catenin (Fig. 4 C) and 
N-cadherin (Fig. 4 D). However, the anti-PTP1B antibody 
also  reveals  some  cytoplasmic  staining  consistent  with 
prior reports (Frangioni et al., 1992). 
Inhibition of the Tyrosine Phosphorylation  of the 
PTP1B-LP  Blocks Its Association with N-Cadherin 
To further clarify the significance of tyrosine phosphoryla- 
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nin  and N-cadherin.  Single cells cultured  on coverslips  coated 
with poly-L-lysine (50 ixg/ml in PBS) were fixed, perrneabilized, 
and  reacted  with  the  indicated  primary antibody followed  by 
rhodamine-labeled second antibody. Each panel represents a dif- 
ferent field. (A and B) Anti-PTP1B  antibody; (C) anti-13-catenin 
antibody; (D) Anti-N-cadherin antibody. Bar, 10 i~m. 
tion of the PTPIB-LP, we assayed the effect of the tyro- 
sine  kinase  inhibitor  genistein  and  the  tyrosine  phos- 
phatase inhibitor phenylarsine oxide on the association of the 
PTP1B-LP with  N-cadherin.  Single  ceils were  incubated 
with or without these  inhibitors prior to homogenization 
and preparation of the H  fraction. The N-cadherin-associ- 
ated fraction was then prepared and analyzed by immuno- 
blot  for  the  presence  of  the  PTP1B-LP  (Fig.  5).  The 
trI'PIB-LP is co-immunoprecipitated with N-cadherin from 
control (untreated) cells and cells treated with phenylars- 
ine oxide, but does not co-immunoprecipitate with N-cad- 
herin from the cells treated with genistein  (see Table I). 
Furthermore, when present the PTP-LP is tyrosine phos- 
phorylated (Fig. 5 A). This suggests that the tyrosine phos- 
phorylation of the phosphatase is essential for its associa- 
tion with the cadherin-catenin complex. 
We further assayed for tyrosine kinase and phosphatase 
activates that co-immunoprecipitate with N-cadherin. Cells 
were treated with genistein or phenylarsine oxide, H  frac- 
tions prepared, and fractionated on anti-N-cadherin affin- 
ity  columns.  The  bound  fraction  was  then  assayed  for 
these activities. The tyrosine kinase inhibitor genistein re- 
sults in the loss of both the kinase and phosphatase activi- 
ties associated with N-cadherin.  In contrast,  the  tyrosine 
phosphatase  inhibitor  phenylarsine  oxide  results  in  the 
loss of only phosphatase activity (Fig. 6). Genistein has no 
effect on phosphatase activity when added during the as- 
Figure 5.  The effect of inhibitors  of tyrosine kinase and tyrosine 
phosphatase on the association of the PTP1B-LP with N-cadherin 
and phosphorylation of the PTP1B-LP.  Single cells were incu- 
bated with the indicated additives, H  fractions prepared and 
immunoprecipitated with Sepharose-conjugated  NCD-2. The im- 
munoprecipitates  were  fractionated  by  SDS-PAGE  and  im- 
munoblotted with anti-PTP1B  antibody or anti-phosphotyrosine 
antibody PY20. As a control,  the same transfer membrane was 
immunoblotted  with  NCD-2  (top).  Co,  control,  no  additives; 
PAO, 10 txg/ml phenylarsine  oxide; Gen, 150 ~M genistein. The 
arrow labeled N-cad indicates  the position  of N-cadherin.  The 
migration of standard proteins is indicated at the left by their mo- 
lecular mass (× 10-3). 
say (not shown). These results are consistent with the idea 
that the phosphorylation of the PTP1B-LP (which is inhib- 
ited  by genistein)  is essential for its association with the 
N-cadherin-catenin complex. 
The  fact that  phosphorylation of the  PTP1B-LP is  re- 
quired for binding to N-cadherin and that genistein leads 
to loss of cadherin-bound PTP1B-LP, suggests that at least 
a  component  of  the  soluble  or  non  cadherin-bound 
PTP1B-LP should lack phosphorylated tyrosine residues. 
To determine if this is the  case, a  cadherin free fraction 
was prepared to insure that no cadherin-bound PTP1B-LP 
was present. To accomplish this, the 14,000 g supernatant 
was fractionated as usual. However, in this case, the mate- 
rial above the 2~0% interface, (i.e., the fraction lacking the 
vast majority of N-cadherin) was collected and further de- 
pleted of N-cadherin by incubation with anti-N-cadherin 
antibody. The unbound fraction was then immunoprecipi- 
tated  with  anti-phosphotyrosine  antibody  (RC20B)  and 
the  bound  and  unbound  fractions  separated  by  SDS- 
PAGE and immunoblotted with anti-PTP1B antibody. Af- 
ter this fractionation, PTP1B-LP was detected only in the 
RC20B unbound fraction (Fig. 7). The RC20B-bound frac- 
tion,  but  not  the  unbound  fraction,  does  contain  several 
other tyrosine-phosphorylated components indicating that 
the  separation of tyrosine-phosphorylated and -nonphos- 
phorylated components by RC20B is effective (not shown). 
Thus, the PTP1B-LP not associated with N-cadherin is not 
tyrosine phosphorylated. Treatment with genistein, which 
releases the PTP1B-LP from its association with cadherin, 
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Figure 6.  Inhibition of protein tyrosine kinase and tyrosine phos- 
phatase  activities in N-cadherin-catenin  complexes. Single cells 
were incubated with the indicated additive, H fractions prepared, 
fractionated  on immobilized anti-N-cadherin  antibody  NCD-2, 
and enzyme activity assayed in the  bound fraction. The results 
are presented as percent activity based on 100% for control cells 
with no additives and 0% for assays carried out in the presence of 
the appropriate inhibitor (4 mM vanadate for the phosphatase as- 
say and 60 ixM piceatannol for the kinase assay). Each point rep- 
resents the mean of duplicate measurements  and bars represent 
deviations from the mean. Gen, 150 txM genistein; PAO, 10 ixg/ml 
phenylarsine oxide. (Left) Tyrosine phosphatase  activity. (Right) 
Tyrosine kinase activity. 
does cause an apparent increase in the amount of nonty- 
rosine-phosphorylated PTP1B-LP; however, this increase 
is small which may reflect the fact that the nontyrosine- 
phosphorylated pool of PTP1B-LP is far larger than the 
tyrosine-phosphorylated, cadherin-bound pool. 
N-Cadherin Binds to 
Tyrosine-phosphorylated PTP1B-LP 
The  association  of the  PTP1B-LP with  N-cadherin sug- 
gests a  direct interaction between the two molecules. To 
determine if the PTPIB-LP interacts directly with N-cad- 
herin, N-cadherin was purified and labeled with biotin to 
use as a probe (Fig. 8, top). The rapidly sedimenting frac- 
tion  (H)  was  immunoprecipitated  with  anti-PTP1B-LP, 
the precipitate fractionated by SDS-PAGE and Western 
transfers prepared as the target. Biotin-labeled N-cadherin 
binds specifically to the same polypeptide recognized by 
the  anti-PTPIB  antibody  (Fig.  8,  bottom).  Furthermore, 
cadherin fails to bind to PTPIB-LP which has been  de- 
phosphorylated. Whether the PTPIB-LP sample is treated 
with alkaline phosphatase after separation by SDS-PAGE 
and transfer (Fig. 8, bottom left)  or before separation by 
SDS-PAGE (not shown), N-cadherin fails to bind to im- 
mobilized PTPIB-LP. Taken together these data demon- 
strate that N-cadherin binds directly to the PTPIB-LP, but 
only when the PTPIB-LP is tyrosine phosphorylated. Ta- 
ble I summarizes the data linking phosphorylation of the 
Figure 7.  PTP1B-LP that is not associated with N-cadherin is not 
tyrosine phosphorylated. Single cells were incubated in the pres- 
ence (Gen) or absence (Co) of genistein, the 14,000  g supernatant 
prepared and fractionated as described for the preparation  of the 
H fraction. The material above the 20/50% sucrose interface was 
incubated with NCD-2 and the precipitates harvested using goat 
anti-rat  IgG conjugated to magnetic beads. The supernatant from 
the NCD-2 fractionation  was further  incubated  with anti-phos- 
photyrosine  antibody  conjugated  to  biotin  (RC20B)  and  the 
bound fractions collected using streptavidin conjugated magnetic 
beads. The bound and unbound  (Flow) fractions were then re- 
solved by SDS-PAGE and immunoblotted with anti-PTP1B anti- 
body. SKN refers to the cell lysate provided by the vendor as a 
PTP1B standard. The migration of standard proteins is indicated 
at the left by their molecular mass (×10-3).  The identity of the 
crossreactive band present in each lane at approximately 60-kD is 
unknown. 
PTP1B-LP,  its  association  with  N-cadherin  and  N-cad- 
herin function. 
Binding of GalNAcPTase Ligands to Cells 
Results in Inhibition of Tyrosine Kinase and Absence 
of PTP1B-LP  from the CadherinlCatenin Complex 
We have previously demonstrated that interaction of the 
retina cell surface GalNAcPTase with a proteoglycan with 
a  250-kD  core protein  (apparently  neurocan)  triggers  a 
signaling  pathway  which  results  in  tyrosine-phosphory- 
lated  13-catenin,  uncoupling of cadherin from its  associa- 
tion with actin, and loss of cadherin function (Balsamo et al., 
1995).  This  effect is  similar  to that shown above for ty- 
rosine kinase and phosphatase inhibitors and suggests that 
inhibition of cadherin-mediated adhesion after interaction 
of the GalNAcPTase with the 250-kD PG ligand might in- 
volve alteration of the activity of one or both of these en- 
zymes. To test this hypothesis, cells were incubated with 
GalNAcPTase ligands, H fractions prepared, and purified 
on an N-cadherin affinity column. Bound material was as- 
sayed for tyrosine kinase and phosphatase activities. Bind- 
ing  of the  250-kD  core protein  as  well  as  anti-GalNAc 
PTase  antibody 1Bll  to cells  bearing the  GalNAcPTase 
results in inhibition of protein tyrosine phosphatase activ- 
ity (Fig. 9, top) and protein tyrosine kinase activity (Fig. 9, 
bottom).  In  contrast,  anti-GalNAcPTase  antibody 7A2, 
which binds equally well to the cell surface GalNAcPTase, 
is without effect, as is a mixture of 400-kD proteoglycan 
core  proteins  including  versican,  aggrecan,  and  phos- 
phacan. 
This is identical to the effects observed with tyrosine ki- 
nase inhibitors, suggesting that the binding of the 250-kD 
PG to the GalNAcPTase results in inhibition of a tyrosine 
kinase which prevents phosphorylation of the PTP1B-LP 
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N-cadherin  to  immobilized 
PTPIB-LP. (Top) Biotin la- 
beled  purified  N-cadherin 
was  fractionated  by  SDS- 
PAGE, transferred to PVDF 
membrane and probed with 
HRP-streptavidin  (a)  or 
NCD-2 (b). The arrow indi- 
cates the position  of N-cad- 
herin.  (Bottom) The PTP1B- 
LP was  immunoprecipitated 
from an H  preparation with 
anti-PTP1B  antibody,  frac- 
tionated by SDS-PAGE and 
transferred  to  PVDF.  The 
membranes  were  incubated 
with  10 U/ml alkaline  phos- 
phatase in the presence (Co) 
or  absence  of (E)  the  phos- 
phatase inhibitor 4 mM o-vanadate (Co). The membranes were 
then reacted with purified,  biotin-labeled  N-cadherin  (biotin/N- 
cad), followed by HRP-streptavidin. The same membranes were 
stripped and reacted with  anti-PTP1B  antibody (anti-PTP1B). 
The arrow labeled PTP indicates  the position of the PTP1B-LP. 
The migration of standard proteins is indicated  at the left by 
their molecular mass (× 10-3). 
and therefore prevents association of the PTP1B-LP with 
N-cadherin.  Indeed,  in  cells  treated  with  anti-GalNAc 
PTase antibody 1Bll or the 250-kD core protein prepara- 
tion, but not anti-GalNAcPTase antibody 7A2 or the 400- 
kD  core  protein,  the  PTP1B-LP  is  not  associated  with 
N-cadherin (Fig. 10). 
Blocking the Tyrosine Phosphorylation 
of fl-Catenin Eliminates the Ability of C,  alNAcPTase 
Ligands and Phosphatase Inhibitors to Inhibit 
Cadherin-mediated Adhesion 
Taken together the results described above indicate that 
binding of the 250-kD PG to the  GalNAcPTase inhibits 
Table L Cadherin-mediated Adhesion Requires Bound, 
Functional PTPIB-LP* 
PTP1B-LP  Phosphatase 
Cadherin  associated  PTP1B-LP  is  associated 
Cell  mediated  with  tyrosine  with 
Treatment  adhesion  N-cadherin  phosphorylated  N-cadherin 
None 
(control)  ~  Yes  Yes  Yes  Yes 
Phenylarsine  No  Yes  Yes  No 
oxide  ~ 
Genistein  I  No  No  No  No 
*For a full explanation of the results summarized here see the data in Fig. 5, 6, and 7. 
~Among control cells cadherin is fully functional.  The PTP1B-LP is tyrosine phos- 
phorylated and bound to the cytoplasmic  domain of N-cadherin. 
~Treatment  of cells with the phosphatase inhibitor,  phenylarsine oxide, inactivates 
cadherin.  The drug directly inhibits N-cadherin-associated phosphatase activity, but 
has no effect on the tyrosine phosphorylation of the PTP1B-LP  or its association with 
N-cadherin. 
ITreatment of cells with the tyrosine kinase inhibitor, genistein, aslo inactivates cad- 
herin.  This drug results in a loss ot N-cadherin-associated phosphatase activity as a 
consequence of the fact that it inhibits the tyrosine phosphorylation of the PTP1B-LP, 
and thus its assocition with N-cadherin. 
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Figure 9.  Inhibition of protein tyrosine kinase and tyrosine phos- 
phatase activities in N-cadherin--catenin complexes in response to 
binding  of GalNAcPTase ligands.  Single  cells  were incubated 
with the indicated  additive, H fractions prepared, fractionated on 
immobilized  anti-N-cadherin antibody NCD-2,  and enzyme ac- 
tivity assayed in bound fraction. The results are presented as per- 
cent activity based on 100% for control cells with no additives 
and 0% for assays carried out in the presence of the appropriate 
inhibitor (4 mM vanadate for the phosphatase assay and 60 ~M 
piceatannol for the kinase assay). Each point represents the mean 
of duplicate  measurements and bars represent deviations  from 
the mean. 7A2, 10 v~g/ml  anti-GalNAcPTase mAb 7A2; 1Bll, 10 
Ixg/ml anti-GalNAcPTase mAb 1Bll; 250, 10 ixg/ml 250-kD core 
proteoglycan; 400, 10 txg/m1400-kD core proteoglycan.  (Left) Ty- 
rosine phosphatase activity; (right) tyrosine kinase activity. 
cadherin-mediated  adhesion  by inhibiting  a  tyrosine  ki- 
nase. This results in lack of phosphorylation of the PTP1B- 
LP, preventing its association with N-cadherin and its abil- 
ity to dephosphorylate 13-catenin.  This hypothesis suggests 
that cells lacking phosphorylated 13-catenin  will form cad- 
herin-mediated  adhesions  in  the  presence  of  GalNAc 
PTase ligands  or  inhibitors  of tyrosine phosphatase.  To 
test this hypothesis we prepared cells with reduced levels 
of phosphotyrosine  residues  by overnight  incubation  in 
culture medium containing herbimycin A. The cells were 
then assayed for the presence of phosphorylated [3-catenin 
and N-cadherin-mediated adhesion in the presence or ab- 
sence of GalNAcPTase ligands or tyrosine phosphatase in- 
hibitors. To ensure that the preincubation resulted in cells 
lacking phosphorylated [3-catenin, the rapidly sedimenting 
fraction (H) was immunoprecipitated with anti-13-catenin 
antibody and analyzed by immunoblot with anti-phospho- 
tyrosine antibody. While the amount of [3-catenin is unaf- 
fected  by prolonged  herbimycin  treatment  (Fig.  11,  top 
left),  the  herbimycin-treated  cells  have  a  significantly 
lower level of phosphorylated tyrosine residues on 13-cate- 
nin than do control cells (Fig. 11, top right). 
While phosphorylated tyrosine residues are presumably 
absent from many cellular proteins following herbimycin 
treatment, the ability of cells to adhere via an N-cadherin- 
mediated mechanism is not compromised as evidenced by 
the ability of anti-N-cadherin to inhibit adhesion. Further- 
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NacPTase ligands  on the as- 
sociation  of  the  PTPIB-LP 
with N-cadherin.  Single cells 
were incubated for 45 rain at 
37°C in the presence of the 
GalNAcPTase mAbs 7A2 or 
1Bll,  or in the  presence of 
the  250-  or  400-kD  pro- 
teoglycans  (see  Fig.  6  for 
concentrations).  H  fractions 
were prepared and fraction- 
ated  using  anti-N-cadherin 
antibody.  The immunoprecipitated material was fractionated by 
SDS-PAGE, transferred to PVDF membrane, and immunoblot- 
ted with anti-PTPiB antibody.  The arrow indicates  the position 
of the PTP1B-LP. The heavy band at ~55 kD is immunoglobulin 
heavy chain. The migration of standard proteins is indicated  at 
the left by their molecular mass (× 10-3). 
more, ~80%  of the  cells are  competent to form N-cad- 
herin-mediated adhesions after incubation in the presence 
or absence of herbimycin. However, after prolonged her- 
bimycin  treatment,  cadherin-mediated  adhesion  is  no 
longer inhibited  by the  250-kD  PG  (not  shown)  or anti- 
GalNAcPTase antibody 1Bll  (Fig.  11, bottom).  Further- 
more,  the  tyrosine  phosphatase  inhibitor  phenylarsine 
oxide is also without effect (Fig. 1I, bottom). These obser- 
vations  suggest  that  prolonged  herbimycin  treatment 
blocks the constitutive phosphorylation of 13-catenin  and 
thereby eliminates the need for an N-cadherin-associated 
tyrosine phosphatase to dephosphorylate ~-catenin in or- 
der to maintain the adhesion competence of ceils. 
Discussion 
Our data indicate that in embryonic chick retina tissue and 
cells the presence of phosphorylated tyrosine residues on 
l~-catenin is inversely related to the association of N-cad- 
herin with the actin containing cytoskeleton and the ability 
of cells to adhere via N-cadherin. Furthermore, the level 
of phosphorylated tyrosine residues on 13-catenin  depends 
on the  function  of a  PTP1B-Iike phosphatase  associated 
with  N-cadherin,  an  association  dependent  on  tyrosine 
phosphorylation of the  PTP1B-LP.  Agents which  inhibit 
the  activity of the  PTP1B-LP (i.e., tyrosine phosphatase 
inhibitors) or its binding to N-cadherin (i.e., tyrosine kinase 
inhibitors or binding of the 250-kD PG to the cell surface 
GalNAcPTase; Balsamo et al., 1995), result in the accumu- 
lation  of phosphorylated tyrosine residues  on  ~-catenin, 
uncoupling  of cadherin  from its  association with the  cy- 
toskeleton and loss of N-cadherin function. 
Phosphorylated Tyrosine Residues on fl-Catenin Are an 
Indicator of  the Integrity of  the Cadherin/Actin Linkage 
The correlation between the presence of phosphorylated 
tyrosine residues on [~-catenin and loss of cadherin-medi- 
ated adhesion is consistent with reports from other labora- 
tories. Transformation of cells bearing E-cadherin with v-src 
leads to an invasive phenotype, with a concomitant loss of 
cadherin function and the presence of phosphorylated ty- 
Figure 11.  Effect of long term treatment of cells with herbimycin 
A  on  phosphorylated  tyrosine  residues  on  ~-catenin  and  on 
N-cadherin-mediated adhesion. Single cells were incubated  over- 
night in medium with or without 1 ~g/ml herbimycin A  and as- 
sayed for phosphorylated tyrosine residues on 13-catenin and cad- 
herin-mediated  adhesion. (Top) Phosphorylated  tyrosine residues 
on 13-catenin. The H fraction was incubated with anti-13-catenin 
antibody and the immunoprecipitated material was fractionated 
by SDS-PAGE and immunoblotted with anti-13-catenin antibody 
or anti-phosphotyrosine antibody.  Co, no additives;/, cells incu- 
bated overnight with herbimycin A. The arrowhead labeled B-cat 
marks the position  of 13-catenin. (Bottom) N-cadherin-mediated 
adhesion.  Single cells were allowed to adhere to microtiter wells 
coated with purified N-cadherin in the presence of the indicated 
additives.  CO, control,  no additives;  1Bll, 10  Ixg/ml anti-Gal- 
NAcPTase mAb 1Bll; NCD, 10 ixg/ml NCD-2; PAO, 10 Ixg/ml 
phenylarsine  oxide.  Results  are presented as percent of control 
values and represent the average of three measurements. Error 
bars indicate the standard deviation. 
rosine residues on ~-catenin (Matsuyoshi et al., 1992; Beh- 
rens  et  al.,  1993).  Similarly, suppression  of N-cadherin- 
mediated adhesion after transformation of chick embryo 
fibroblasts  with  Rous  sarcoma virus  correlates  with  the 
presence of phosphorylated tyrosine residues on 13-catenin 
(and  et-catenin)  (Hamaguchi  et  al.,  1993).  Treatment  of 
human carcinoma cells with hepatocyte growth factor or 
epidermal growth factor enhances dispersal of cells, con- 
comitant with the appearance of phosphorylated tyrosine 
residues on 13-catenin  (Shibamoto et al., 1994). 
In contrast to other reports (Matsuyoshi et al., 1992; Beh- 
rens et al., 1993,  Hamaguchi et al., 1993,  Shibamoto et al., 
1994) we do not find tyrosine phosphorylated B-catenin to 
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pernatant  analyzed here includes  the Triton X-100 high 
speed supernatant analyzed in these other studies. These 
observations may be reconciled if the presence of phos- 
phorylated tyrosine residues on ~3-catenin does not com- 
pletely eliminate the ability of [3-catenin to interact with cad- 
herin,  but  rather reduces its  affinity for cadherin.  Thus 
there may be a small amount of tyrosine-phosphorylated 
13-catenin that remains associated with cadherin, but this 
comprises a very small proportion when compared to ty- 
rosine-phosphorylated 13-catenin not associated with N-cad- 
herin. Furthermore, the ability to detect this residual pop- 
ulation of tyrosine-phosphorylated 13-catenin associated with 
cadherin may depend on the cells being examined and the 
specific techniques being used. 
We have previously shown that loss of cadherin function 
is correlated with loss of the association of cadherin with 
actin in both epithelial (Bauer et al., 1992) and neural cells 
(Balsamo et al., 1991, 1995). In this manuscript we extend 
these observations, showing that tyrosine kinase and phos- 
phatase inhibitors also result in loss of cadherin-mediated 
adhesion  and loss of the integrity of the cadherin-actin 
connection. A recent study of adherens junctions also sug- 
gests that the behavior of a rapidly sedimenting fraction, 
similar to our H  fraction, reflects the function of E-cad- 
herin. After ras transformation, the integrity of the adher- 
ens junction and the function of E-cadherin are compro- 
mised. This is correlated with displacement of 13-catenin 
from a rapidly sedimenting pool into a  soluble pool and 
the detection of tyrosine-phosphorylated 13-catenin prima- 
rily in  the  soluble  pool.  Furthermore,  after herbimycin 
treatment of ras-transformed cells, which decreases phos- 
phorylation of many proteins and restores the integrity of 
the adherens junction, 13-catenin is found in a rapidly sedi- 
menting fraction in association with E-cadherin (Kinch 
et al., 1995). 
A PTPIB-LP Is Associated  with N-Cadherin 
Our data strongly suggest that the dephosphorylation of 
tyrosine residues in 13-catenin is essential for cells to form 
cadherin-mediated adhesions and that this depends on a 
PTP1B-LP  associated  with  N-cadherin  and  the  N-cad- 
herin-catenin complex. Conditions which prevent associa- 
tion of the PTP1B-LP with N-cadherin (inhibition of ty- 
rosine kinase activity), or which result in loss of PTP1B-LP 
activity (inhibition  of tyrosine phosphatase  activity), in- 
variably lead to the  accumulation of phosphorylated ty- 
rosine residues  on  13-catenin  and loss of cadherin-medi- 
ated adhesion. 
The association of the PTP1B-LP with N-cadherin is ev- 
idenced by their co-isolation. The significance of this inter- 
action is most effectively illustrated by the lack of associa- 
tion  of  the  PTP1B-LP with  cadherin  under  conditions 
which result in loss of cadherin function (the presence of 
tyrosine kinase inhihitors or GalNAcPTase ligands). More- 
over we have shown that purified N-cadherin interacts di- 
rectly with the PTP1B-LP on Western transfers. 
The  association  of  the  PTP1B-LP  with  cadherin  de- 
pends on the phosphorylation state of tyrosine residues on 
the PTPIB-LP; only tyrosine phosphorylated PTP1B-LP is 
associated with cadherin.  This association is  blocked by 
drugs  that  prevent  tyrosine  phosphorylation.  Further- 
more, removal of phosphate from the PTP1B-LP prevents 
its  association  with  N-cadherin  as  assayed  by  Western 
overlays. The transmembrane phosphatase PTPIx has also 
been reported to associate with the intracellular domain of 
cadherin (Brady-Kalnay et al., 1995); however, it is not yet 
possible  to  determine  if the  two  phosphatases  interact 
through the same or an overlapping domain. A key differ- 
ence may be the requirement for tyrosine phosphorylation 
of the PTP1B-LP in order for it to interact with N-cad- 
herin. 
The  requirement  for  tyrosine phosphorylation  of the 
PTP1B-LP to bind to N-cadherin implicates a tyrosine ki- 
nase as a critical component of the signaling pathway con- 
trolling the level of phosphorylated tyrosine residues on 
[3-catenin and therefore cadherin function. Whether this 
kinase is the same one that is required for tyrosine phos- 
phorylation of [3-catenin (see discussion below) remains to 
be determined. 
Analysis of recombinant PTP's has revealed several dis- 
tinct sequences which target them to specific cellular loca- 
tions (Mauro and Dixon, 1994).  However, more relevant 
to our studies, tyrosine phosphorylation of PTP's has been 
demonstrated to produce a consensus site for interaction 
with SH2 domains (Sun and Tonks,  1994).  We searched 
the  carboxy terminal cytoplasmic domain of N-cadherin 
for SH2 (see Margolis, 1992) domains and as well as PID 
domains which also are recognized by peptides containing 
phosphorylated tyrosine residues  (Kavanaugh  and  Will- 
iams, 1994). We were unable to identify unequivocally any 
such sequence motifs in N-cadherin. This suggests that ty- 
rosine  phosphorylated  PTP1B-LP  interacts  with  a  se- 
quence motif present in N-cadherin not (yet) recognized 
as a site for interaction with phosphorylated tyrosine resi- 
dues or that phosphorylated tyrosine residues are not di- 
rectly involved in this interaction. 
We have referred to the PTPIB immunoreactive species 
as a PTP1B-Iike phosphatase because of its immunological 
cross reactivity with characterized antibodies and the simi- 
larity of its apparent molecular mass to the human placen- 
tal enzyme (Tonks et al., 1988). The monoclonal antibody 
used in these studies was prepared against a protein frag- 
ment corresponding to amino acids 269 through 435 of the 
human enzyme. This sequence encompasses a portion of 
the conserved phosphatase domain and the COOH-termi- 
nal 35-amino acid targeting domain and could well cross- 
react with other related PTP's. PTP1B has been reported 
to be primarily localized to the endoplasmic reticulum by 
virtue of the COOH-terminal targeting domain (Frangioni 
et al.,  1992).  However, it has been stated that PTP1B is 
also present at focal adhesions (Mauro and Dixon, 1994), a 
locale more in keeping with the localization of the tyrosine 
phosphatase identified in this study. While these similari- 
ties suggest that the tyrosine phosphatase identified here is 
closely  related  to  PTP1B,  definitive  identification  will 
have to await molecular characterization. 
PhosphorylationlDephosphorylation  of [3-Catenin: a 
Dynamic Equilibrium 
Our data suggest the hypothesis that there is an equilib- 
rium between phosphorylation and dephosphorylation of 
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toskeletal linkage (Fig. 12). This equilibrium may be per- 
turbed by a variety of transmembrane signals altering cell 
behavior during development. For example, binding of a 
250-kD PG to the GalNAcPTase results in inhibition of 
cadherin-mediated  adhesion  concomitant with the  accu- 
mulation of phosphorylated tyrosine residues on 13-catenin 
and uncoupling of cadherin from its association with the 
actin containing cytoskeleton (Balsamo et al., 1995). 
Here we show that the increased levels of phosphory- 
lated tyrosine residues on [3-catenin after binding of the 
250-kD PG appear to be due to inhibition of a tyrosine 
kinase  activity  essential  for  the  phosphorylation  of the 
PTP1B-LP, binding of the PTP1B-LP to N-cadherin and 
dephosphorylation of [3-catenin.  Lack of PTPIB-LP bound 
to N-cadherin is correlated with the accumulation of phos- 
phorylated tyrosine residues on 13-catenin. As one test of 
this proposed chain of events, we incubated cells overnight 
in the presence of a protein tyrosine kinase inhibitor in or- 
der to  prepare cells which lack  phosphorylated tyrosine 
residues on [3-catenin.  Cadherin-mediated adhesion among 
these cells occurs at a normal level; however, this adhesion 
is no longer inhibited by the 250-kD PG or by inhibitors of 
tyrosine kinase  or phosphatase.  Thus, inhibition of cad- 
herin-mediated  adhesion  through  the  interaction  of the 
250-kD  PG with  the  GalNAcPTase  or by inhibitors  of 
tyrosine kinase and phosphatase requires that cells are ca- 
pable of phosphorylating 13-catenin and further reinforces 
our conclusion that regulated removal of phosphate from 
13-catenin is a critical event controlling cadherin function. 
Together these data suggest that, under normal conditions, 
there is  a  dynamic equilibrium between phosphorylation 
and dephosphorylation of tyrosine residues on [3-catenin 
(see Fig. 12). 
Binding of ligand to two transmembrane tyrosine kinase 
receptors, the epidermal growth factor and the scatter fac- 
tor/hepatocyte  growth  factor  receptors,  has  also  been 
shown  to  result  in  accumulation  of phosphorylated  ty- 
rosine residues on 13-catenin and the loss of cadherin-me- 
diated adhesion (Shibamoto, 1995). The cytoplasmic do- 
main  of  the  EGF  receptor  tyrosine  kinase  has  been 
reported to associate directly with [3-catenin and to phos- 
phorylate 13-catenin  on activation by EGF (Hoschuetzky 
et al., 1994). The closely related transmembrane tyrosine 
kinase c-erbB-2 (Yamamoto et al., 1986) has also been re- 
ported to associate directly with 13-catenin  (Ochiai et al., 
1994b; Kanai et al., 1995) and is thus positioned appropri- 
ately  to  directly phosphorylate  13-catenin  and  therefore 
downregulate cadherin function. Consistent with this pos- 
sibility,  amplification  or  overexpression of c-erbB-2  has 
been correlated with  highly malignant  tumors and  poor 
prognosis (Slamon et al., 1987). The SF/HGF-receptor, c-met, 
may act similarly. As the name implies, interaction of SF/ 
HGF with its receptor does appear to be one trigger for 
cells to assume a migratory phenotype (i.e., lose their char- 
acteristic cell-cell adhesion). Indeed, the interaction of SF/ 
HGF with c-met is essential for the migration of myogenic 
precursors into the limb (Bladt et al., 1995). In each case, 
the increased tyrosine phosphorylation of [3-catenin may 
overwhelm the  ability of the  PTP1B-LP or  other phos- 
phatases to dephosphorylate [3-catenin, resulting in loss of 
cadherin-mediated adhesion. 
While the 250-kD PG/GalNAcPTase interaction, as well 
as interaction of transmembrane receptor tyrosine kinases 
with their receptors, have the potential to downregulate 
cadherin function, the transmembrane phosphatase PTPp~ 
has the potential to upregulate cadherin function in much 
the same manner as we are proposing for the PTP1B-LP. 
PTPIx interacts directly with N-cadherin (Brady-Kalnay 
et al., 1995) and may be specifically activated through ho- 
mophilic interaction (Brady-Kalnay et al., 1993) creating 
opportunities for temporal or spatial control of cadherin 
function. We have not yet determined if the PTP1B-LP 
and the PTP~ are both present in the same complex. The 
presence of two distinct phosphatases in the same complex 
might add  to the potential for precise control of N-cad- 
herin function through the interaction of other cell surface 
proteins with their ligands. One set of signals may cause 
inactivation or loss of the PTPIB-LP, increasing the accu- 
mulation of phosphorylated tyrosine residues on 13-cate- 
nin; another set of signals may activate the transmembrane 
phosphatase, thereby reducing the level of phosphorylated 
tyrosine residues on 13-catenin. 
Our hypothesis is also consistent with the effect of ki- 
nase and phosphatase inhibitors on the integrity of adher- 
ens junctions which depend on E-cadherin. We propose 
that junctional integrity is lost after treatment with phos- 
phatase inhibitors due to the inability of cells to dephos- 
Figure  12.  Diagram  depict- 
ing the effect of the phospho- 
rylation  or  dephosphoryla- 
tion of the PTP1B-LP on its 
association  with  N-cadherin 
and  the  concomitant  alter- 
ation in the state  of tyrosine 
phosphorylation  of  [3-cate- 
nin and the integrity  of the 
N-cadherin-actin  connec- 
tion.  Our  data  suggest  that 
tyrosine  phosphorylation  of 
the PTP1B-LP results  in its 
association with N-cadherin, 
dephosphorylation  of 13-catenin,  and association of N-cadherin with the actin containing cytoskeleton (via a- and [3-catenin),  resulting in 
adhesion competent cells. In contrast, dephosphorylation  of the PTP1B-LP results in its inability to associate with N-cadherin, accumu- 
lation of phosphorylated tyrosine residues on 13-catenin,  dissociation of the cadherin-actin connection, and loss of adhesive competence. 
The illustrated changes in intermolecular association involving a-catenin are speculation. 
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tional  integrity  by  tyrosine  kinase  inhibitors,  after 
transformation of cells with src, may be due to a reduction 
in the rate or level of tyrosine phosphorylation of 13-cate- 
nin  (Volberg et al., 1992;  see also Kinch  et al.,  1995).  It 
should be emphasized that these effects are seen following 
long  term  incubations  and  are  analogous  to  the  results 
seen in our system after long term incubation with tyrosine 
kinase  inhibitors.  While src is present  at  adherens  junc- 
tions (Tsukita et al., 1991)  and could directly phosphory- 
late  13-catenin,  it is not yet clear whether 13-catenin is in 
fact phosphorylated directly by src or by a more complex 
pathway involving other kinases. 
In summary, [3-catenin  appears to play a central role in 
the  translation  of extracellular  information  into  altered 
cadherin function.  One class of external ligands:  e.g., the 
250-kD PG, hepatic growth factor and epidermal growth 
factor, bind to specific cell surface receptors, decreasing 
the stability of cadherin-mediated  adhesion by maintain- 
ing a high level of phosphorylated  tyrosine residues on 
13-catenin. At least two distinct pathways are possible: loss 
of the ability to remove phosphorylated tyrosine residues 
from 13-catenin due to loss of the PTP1B-LP from the cad- 
herin-catenin complex, as demonstrated for binding of the 
250-kD  PG; and enhanced phosphorylation  of [3-catenin, 
through  direct  activation  of associated  tyrosine  kinases, 
the likely explanation for the effects of EGF and HGF. A 
second class of ligands,  e.g., the  Wnt gene product,  also 
probably bind to specific cell surface receptors, resulting in 
an  increase  in  the  amount  of 13-catenin  associated  with 
cadherin and increasing the stability of cadherin-mediated 
adhesion (Hinck et al., 1994a; Bradely et al., 1994). Thus, 
cadherin function may be controlled through the  activa- 
tion of at least  two distinct types  of signaling  pathways, 
both ramifying on the stability and/or extent of linkage of 
cadherins  with  the  cytoskeleton  (see  also  Hinck  et  al., 
1994b). We are just beginning to appreciate the diversity 
of molecular interactions impinging on control of cadherin 
function. It is already clear that the temporal and spatial 
control of cadherin function through ligand receptor inter- 
actions,  which  themselves  are  temporally  and  spatially 
controlled,  has  the  potential  to  profoundly  affect  the 
course of development. 
Received for publication  15 December 1995 and in revised form 23 April 
1996. 
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